Benefits strategy now sits at the crossroads of sustained healthcare inflation, pharmacy volatility, pay transparency mandates, and rising workforce expectations. Specialty drug exposure and emerging therapies are driving long-term cost pressure, while employees demand personalization, flexibility, and visible value. Incremental plan tweaks are no longer enough. The real question is whether Total Rewards operates as a collection of programs—or as a coherent strategic system aligned to retention, productivity, and long-term financial sustainability.
This Session Will Examine:
- Rewards System Fragmentation: Disconnected pay, health, and wellbeing decisions diluting strategic impact and workforce clarity.
- Pharmacy Volatility Exposure: Specialty and high-cost therapy inflation pressuring budgets and testing employee trust.
- Customization Creep: Expanding personalization increasing complexity, inequity risk, and administrative burden.
- Impact Measurement Blind Spots: Rewards performance tracked through utilization rather than workforce outcomes.
- Vendor Proliferation Risk: Expanding point-solution ecosystems outpacing governance, integration, and accountability discipline.